Dyadic International (NASDAQ:DYAI) Stock Passes Above Fifty Day Moving Average – Time to Sell?

Dyadic International, Inc. (NASDAQ:DYAI)’s stock price passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $1.56 and traded as high as $1.99. Dyadic International shares last traded at $1.73, with a volume of 171,662 shares.

Analysts Set New Price Targets

Separately, HC Wainwright reiterated a “buy” rating and set a $6.00 target price on shares of Dyadic International in a report on Thursday, November 14th.

Dyadic International Trading Down 4.3 %

The company has a fifty day simple moving average of $1.57 and a two-hundred day simple moving average of $1.39. The company has a quick ratio of 5.15, a current ratio of 5.15 and a debt-to-equity ratio of 1.54. The stock has a market capitalization of $48.82 million, a P/E ratio of -7.17 and a beta of 0.89.

Dyadic International (NASDAQ:DYAI) last issued its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported ($0.01) EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.06. The company had revenue of $1.96 million for the quarter, compared to analyst estimates of $1.05 million. Dyadic International had a negative return on equity of 149.16% and a negative net margin of 188.09%. During the same period in the previous year, the company posted ($0.06) earnings per share. On average, sell-side analysts expect that Dyadic International, Inc. will post -0.18 earnings per share for the current year.

Institutional Trading of Dyadic International

An institutional investor recently raised its position in Dyadic International stock. Chapin Davis Inc. lifted its stake in Dyadic International, Inc. (NASDAQ:DYAI) by 2.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 868,301 shares of the biotechnology company’s stock after acquiring an additional 21,000 shares during the quarter. Chapin Davis Inc. owned approximately 2.97% of Dyadic International worth $903,000 as of its most recent SEC filing. 27.95% of the stock is currently owned by institutional investors and hedge funds.

Dyadic International Company Profile

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.